在患有糖尿病的年轻人中,糖尿病技术利用的差异
Puja Singh1,2, Antonio Garcia3, Ellen K Grishman4,5
1Department of Pediatrics, The University of Texas Southwestern Medical Center, Dallas, Texas, USA pusingh@health.ucsd.edu.
BMJ open diabetes research & care
|November 5, 2025
概括
在青少年糖尿病技术使用方面存在种族和民族差异,代表性不足的群体不太可能使用连续血糖监测器 (CGM) 和胰岛素. 提供者通常依赖主观因素,导致这些不平等.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 健康差距 研究 研究 研究 研究
- 糖尿病 技术 技术
背景情况:
- 糖尿病技术,包括持续血糖监测器 (CGM) 和胰岛素,为控制血糖变化和改善糖尿病年轻人的结果提供了显著的好处.
- 尽管有这些优势,但在患者获得和使用这些改变生活的技术方面仍然存在显著的差异.
研究的目的:
- 调查儿童糖尿病患者使用糖尿病技术的种族,种族和社会经济差异.
- 识别医疗保健提供者,患者和护理人员认为的技术采用障碍.
主要方法:
- 从一个大型城市儿科医院的技术使用 (CGM和) 和人口统计数据的回顾性分析.
- 对医疗保健提供者 (医生,执业护士,糖尿病教育者) 进行关于处方习惯的调查.
- 由患有糖尿病的儿科患者 (8-17岁) 和他们的护理人员完成的调查,以评估糖尿病技术的态度和感知好处/负担.
主要成果:
- 与非西班牙裔白人 (NHW) 年轻人相比,非西班牙裔黑人 (NHB) 和患有1型糖尿病的西班牙裔年轻人使用胰岛素或CGM的可能性明显低,无论他们的保险状况如何.
- 与医生相比,糖尿病教育者优先考虑主观因素 (家长教育,健康素养) 而不是客观的适用性标准.
- 来自代表性不足的种族/种族群体的患者和护理人员在诊断后稍晚获得了有关糖尿病技术的信息,并报告了较低的技术采用率.
结论:
- 糖尿病技术使用的显著差异在患有糖尿病的年轻人中是显而易见的,特别影响NHB和西班牙裔人口.
- 供应商对技术资格的评估往往依赖于主观变量,可能加剧现有的不平等.
- 虽然提供者认为技术使用存在障碍,但患者和护理人员表达了积极的态度和低感知负担,突出了理解和解决利用挑战的脱节.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Diabetes: Management and Pharmacotherapy
856
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
856
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Insulin: Dosing Regimen and Adverse Effects
670
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
670
Diabetes: Symptoms, Diagnosis, and Complications
2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K


